<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF MD2PATIENT, INC. FOR THE NINE MONTHS ENDED SEPTEMBER 30,
2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                         292,204
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               347,150
<PP&E>                                         515,679
<DEPRECIATION>                                  85,769
<TOTAL-ASSETS>                               2,961,331
<CURRENT-LIABILITIES>                        5,954,288
<BONDS>                                              0
                                0
                                     50,000
<COMMON>                                       185,213
<OTHER-SE>                                  (3,733,910)
<TOTAL-LIABILITY-AND-EQUITY>                 2,961,331
<SALES>                                        230,765
<TOTAL-REVENUES>                               230,765
<CGS>                                                0
<TOTAL-COSTS>                                7,957,157
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              80,416
<INCOME-PRETAX>                             (7,769,528)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (7,769,528)
<EPS-BASIC>                                      (0.30)
<EPS-DILUTED>                                    (0.30)


</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission